MINDY1 and liver cancer: In summary, MINDY1 and PD-L1 mRNA expression levels are positively correlated in liver cancer, and MINDY1 can inhibit PD-L1 ubiquitination to mediate immune escape in liver cancer, thereby preventing the malignant progression of the disease.